International Flavors & Fragrances (IFF)
Creates flavors, fragrances, enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers.
Something off on this page? Send us feedback.
Creates flavors and fragrances plus enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers, pairing proprietary formulations with customer application work. Continuing operations center on Taste, Scent, and Health & Biosciences, while Food Ingredients is classified as discontinued operations under an agreed sale.
Develops flavor compounds, natural taste solutions, fragrances, enzymes, cultures, probiotics, and other biotechnology-derived inputs used by food, beverage, home-care, personal-care, wellness, and industrial manufacturers. Continuing operations are organized as Taste, Scent, and Health & Biosciences: Taste builds flavor systems; Scent creates fine and consumer fragrances plus fragrance ingredients; Health & Biosciences supplies enzymes, cultures, probiotics, and specialty ingredients for food and non-food applications.
Combines consumer research, proprietary formulations, biotechnology, and application laboratories to adapt ingredients to customers' products across global markets. Production depends on a wide range of natural and synthetic raw materials and compliance with food, personal-care, animal-feed, and environmental rules. Food Ingredients is reported as discontinued operations under an agreed sale whose closing remains subject to regulatory approvals.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 10, 2026 | KeyBanc | Initiate | Rating: — | |
| Aug 7, 2026 | Barclays | Reiterate | Rating: —Target: $90 | Target: $96 |
| Aug 6, 2026 | Robert W. Baird | Target | Target: $90 | Target: $100 |
| Aug 6, 2026 | UBS | Reiterate | Rating: —Target: $75 | Target: $91 |
| Aug 6, 2026 | Oppenheimer | Reiterate | Rating: —Target: $90 | Target: $95 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $569.0M · Total debt $6.24B · Total assets $25.15B · Shareholders' equity $13.98B
- Revenue
- $1.95B
- Operating income
- $158.0M
- Net income
- $50.0M
HistoryDividendAnnual yield
| Institutions | 107.23% | 273.61M shares | |
|---|---|---|---|
| 770 holders · as of Jun 30, 2026 | |||
| Insiders | 6.21% | 15.84M shares | |
| 25 holders · as of Aug 10, 2026 | |||
| Strategic holders | 9.94% | 25.36M shares | |
| 1 holder · as of Feb 14, 2025 | |||
| Adds to | 123.38% | ||
255.15M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 123.38%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Dodge & CoxInstitution | 14.50% | 37.01M | as of Jun 30, 2026 |
Freemont Capital Pte LtdInstitution | 9.94% | 25.36M | as of Jun 30, 2026 |
Winder Pte. Ltd.Strategic | 9.94% | 25.36M | filed Feb 14, 2025 |
BlackRock, Inc.Institution | 9.08% | 23.18M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.37% | 16.26M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | de Mendonca Ana Paula Teles | officer: President, Scent | −5,718 | $83.19 |
| Aug 7, 2026 | Marc Birenkrant | officer: Controller & CAO | −1,000 | $85.00 |
| Aug 6, 2026 | Michael DeVeau | officer: EVP, CFO | −8,825 | $85.55 |
| Jun 1, 2026 | Paul J. Fribourg | director | +273,500 | $74.29 |
| Mar 24, 2023 | Mark J. Costa | director | +10 | $84.27 |
- Archer Daniels Midland
Large-scale food ingredients, flavors, proteins, and sweeteners overlap
- Sensient Technologies
Mid-sized flavors, extracts, colors, and specialty ingredients peer
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| International Flavors & Fragrances | $85.76 | +2.58% | $21.34B | 77.4 | 25.0 | 2.1 | −29.3% |
| Archer Daniels Midland | $82.93 | −0.54% | $40.19B | 22.8 | 14.0 | 0.5 | +7.2% |
| Sensient Technologies | $132.09 | +1.88% | $5.52B | 34.9 | 29.8 | 3.2 | +11.6% |
| Median | 28.9 | 21.9 | 1.9 | +9.4% |